Editing Pregabalin

[[File:Pregabalin Molecular Structure.png|150x150px|thumb|Pregabalin Molecular Structure]]
Pregabalin, marketed under the brand name [[Lyrica]] among others, is a medication used to treat epilepsy, neuropathic pain, [[fibromyalgia]], generalized anxiety disorder, [https://www.mayoclinic.org/diseases-conditions/diabetic-neuropathy/symptoms-causes/syc-20371580 diabetic nerve pain], pain after [[shingles]], [[spinal cord]] injury nerve pain, and partial onset [[seizure]]s in adults (an add-on treatment) with [[epilepsy]].  It is very similar to [[gabapentin]], both chemically and pharmacologically. 

Lyrica® is manufactured by the US pharmaceutical company, Pfizer, Inc.<ref>{{Cite web|url=https://www.pfizer.com/products/product-detail/lyrica_and_lyrica_cr| title = LYRICA® and LYRICA®CR (pregabalin) and (pregabalin extended release tablets) {{!}} Pfizer: One of the world's premier biopharmaceutical companies|website=pfizer.com|language=en|access-date=2018-08-12}}</ref>
==Side Effects==
[[File:Lyrica 150mg box in Finland 20110618.jpg|alt=Box of Lyrica capsules |thumb|Lyrica is a brand name for pregabelin.]]
This information contains side effect information about pregabalin, Lyrica's active ingredient. Some of the dosage forms listed on this page may not apply to the brand name Lyrica.

Always review a drug company's prescription drug's side effects and possible drug interactions with your doctor and pharmacist. 

Pregnant women must always consult with their doctor and pharmacist when taking any prescription drug, over-the-counter drug, supplement, or herbal remedy for side effects, drug interactions, and possible miscarriage, injury, birth defect, addiction, or death to the embryo, fetus, or baby. Breastfeeding women should always talk to their doctor and pharmacist for information about breast milk being laced with the drug she has taken causing side effects, injury, addiction, or death, and drug interactions to the baby consuming her breast milk.

Check with your doctor and pharmacist before using any prescription or over-the-counter drug, supplement, or herbal remedy being administered to a child. Check with your doctor and pharmacist for children's side effects or drug interactions that may not be listed. 

=== More commonly reported side effects ===
 
<div style="column-count:2;">
*Accidental injury
*bloating or swelling of the face, arms, hands, lower legs, or feet
*blurred vision
*burning, tingling, numbness or pain in the hands, arms, feet, or legs
*change in walking and balance
*clumsiness
*confusion
*dementia
*difficulty having a bowel movement
*difficulty with speaking
*double vision
*dry mouth
*false beliefs that cannot be changed by facts
*fever
*headache
*hoarseness
*increased appetite
*lack of coordination
*loss of memory
*lower back or side pain
*painful or difficult urination
*problems with memory
*rapid weight gain
*sensation of pins and needles
*shakiness
*sleepiness
*stabbing pain
*trembling, or other problems with muscle control or coordination
*unsteady walk
*unusual drowsiness
*unusual weight gain or loss<ref name=":0">{{Cite news | url=https://www.drugs.com/sfx/lyrica-side-effects.html| title = Lyrica Side Effects in Detail - Drugs.com|work=Drugs.com|access-date=2018-08-12|language=en-US}}</ref>
</div>

=== Less commonly reported ones are: ===

<div style="column-count:2;">
*Anxiety
*bloated or feeling of fullness
*chest pain
*cold sweats
*cool, pale skin
*cough producing mucus
*decrease or change in vision
*depression
*excess air or gas in the stomach or intestines
*eye disorder
*false or unusual sense of well-being
*general feeling of discomfort or illness
*increased hunger
*loss of appetite
*loss of bladder control
*loss of consciousness
*loss of strength or energy
*muscle aches, twitching or jerking, or weakness
*nausea
*nervousness
*nightmares
*noisy breathing
*pain
*passing gas
*rhythmic movement of the muscles
*runny nose
*seizures
*shivering
*slurred speech
*sweating
*trouble sleeping
*twitching
*uncontrolled eye movements
*vomiting<ref name=":0" />
</div>

=== Other less commonly reported ones are: ===
*Difficult or labored breathing
*tightness in the chest<ref name=":0" />

=== Rarely reported ones are: ===
<div style="column-count:2;">
*Blistering, peeling, or loosening of the skin
*chills
*cough
*diarrhea
*difficulty with swallowing
*dizziness
*fast heartbeat
*hives, itching, skin rash
*joint or muscle pain
*puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
*red skin lesions, often with a purple center
*red, irritated eyes
*sore throat
*sores, ulcers, or white spots in the mouth or on the lips
*unusual tiredness or weakness<ref name=":0" />
</div>

== Generic legal battle ==
*2012, Pfizer blocked multiple drug manufacturers from selling pregabalin, a generic version of Pfizer's drug Lyrica.<ref name=":2">{{Cite news | url=https://www.reuters.com/article/pfizer-lyrica-ruling-idUSL2E8IJJQV20120719| title = Court upholds Pfizer's Lyrica patent protection | last = | first =  | date = 2012-07-19|work=Reuters|access-date=2021-03-09|archive-url=|archive-date=|url-status=|language=en|quote=}}</ref>

*July 2012, the U.S. [[Food and Drug Administration]] (FDA) approved a generic version of Lyrica. Pregabalin, the active ingredient, is the generic name.<ref>{{Cite news | url=https://www.reuters.com/article/us-lupin-lyrica-idUSBRE8640Y220120705| title = U.S. OKs Lupin generic of Pfizer nerve pain drug | last = | first =  | date = 2012-07-05|work=Reuters|access-date=2021-03-09|archive-url=|archive-date=|url-status=|language=en|quote=}}</ref>  Two weeks after being approved by the FDA, marketing was blocked by  Pfizer.<ref name=":2" />

*2014, Pfizer Inc., the maker of Lyrica, successfully blocked the marketing of Pregabalin generics until December of 2018 arguing that the generics should not be marketed and made available until their patent ran out.<ref>{{Cite news | url=https://www.bloomberg.com/news/articles/2014-02-06/pfizer-wins-ruling-to-block-generic-lyrica-until-2018| title = Pfizer Wins Ruling to Block Generic Lyrica Until 2018 | last = Decker | first = Susan | date = Feb 6, 2014|work=Bloomberg Business|access-date=|archive-url=|archive-date=|url-status=}}</ref> Warner-Lamber, (a subsidiary of Pfizer), "still holds a “second medical use” patent for the use of pregabalin in the treatment of peripheral and central neuropathic pain, which expires in July 2017. A second medical use patent is one that relates to a new medical use for a known compound."<ref>{{Cite journal | last = Wise | first = Jacqui | date = 2015-03-30| title = Doctors are warned not to prescribe generic pregabalin for pain control|url=https://www.bmj.com/content/350/bmj.h1724|journal=BMJ|language=en|volume=350|pages=h1724|doi=10.1136/bmj.h1724|issn=1756-1833|pmid=25825288}}</ref>
* Nov 2018, [https://investors.pfizer.com/investor-news/press-release-details/2018/Pfizer-Receives-Six-Months-Pediatric-Exclusivity-for-LYRICA-pregabalin/default.aspx Pfizer Receives Six Months Pediatric Exclusivity For Lyrica® (Pregabalin)]<ref name=":02">{{Cite web|url=https://investors.pfizer.com/investor-news/press-release-details/2018/Pfizer-Receives-Six-Months-Pediatric-Exclusivity-for-LYRICA-pregabalin/default.aspx| title = Pfizer Receives Six Months Pediatric Exclusivity for LYRICA® (pregabalin) | last = | first = | authorlink =  | date = Nov 27, 2018 | website = investors.pfizer.com|language=en-US|archive-url=|archive-date=|url-status=|access-date=2018-12-27}}</ref>
<blockquote>Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted pediatric exclusivity for LYRICA<sup>®</sup>. This grant extends the period of U.S. market exclusivity for LYRICA by an additional six months, to June 30, 2019.<ref name=":02" /></blockquote>
* July 22, 1019, FDA approves first generics of Lyrica<ref name=":1">{{Cite web|url=http://www.fda.gov/news-events/press-announcements/fda-approves-first-generics-lyrica | title = FDA approves first generics of Lyrica | last = Commissioner | first=Office of the | date = 2019-09-11 | website = FDA|language=en|access-date=2019-10-11}}</ref>
<blockquote>On July 19, the [[U.S. Food and Drug Administration]] approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, as an adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older, for the management of [[fibromyalgia]], and for the management of neuropathic pain associated with [[spinal cord]] injury.<ref name=":1" /></blockquote>

== Lyrica patient assistance ==
These assistance programs come with various insurance coverage limitations and income thresholds.
*[https://www.lyrica.com/co-pay-savings-card Co-pay Card]
*[https://www.pfizerrxpathways.com/sites/default/files/attachment/GroupDEngMay2017_0.pdf Patient Assistance Program] Check eligibility on [http://www.pfizerrxpathways.com/?step=1 Pfizer Rx Pathways]
== See also ==
*[[Fibromyalgia]]
*[[Neurontin]] (Gabapentin)
*[[Baclofen]]

==Learn more==
* [https://www.youtube.com/watch?v=S3CmUJyVBbQ&feature=youtu.be&t=3m1s Alan Light - Segment 3: Update on Dr. Light's Recent CFS and FM Research]<ref>{{Cite web|url=https://www.youtube.com/watch?v=S3CmUJyVBbQ&feature=youtu.be&t=3m1s| title = Alan Light - Segment 3: Update on Dr. Light's Recent CFS and FM Research | last = | first = | authorlink = Alan Light | date = Feb 22, 2016 | website = YouTube|publisher=Richard Podell|archive-url=|archive-date=|url-status=|access-date=}}</ref> 
* [https://www.lyrica.com/frequently-asked-questions Frequently Asked Questions by Lyrica][[Lyrica|<sup>®</sup>]] FAQ's for each condition Lyrica is prescribed for. 
* [https://www.painnewsnetwork.org/stories/2017/1/31/lyrica-and-cymbalta-recommended-for-diabetic-neuropathy Lyrica and Cymbalta Recommended for Diabetic Neuropathy]<ref>{{Cite news | url=https://www.painnewsnetwork.org/stories/2017/1/31/lyrica-and-cymbalta-recommended-for-diabetic-neuropathy| title = Lyrica and Cymbalta Advised for Diabetic Neuropathy | last = Anson | first = Pat | date = Jan 31, 2017|work=Pain News Network|access-date=2018-08-12|archive-url=|archive-date=|url-status=|language=en-US}}</ref> (Diabetic nerve pain.) 
*[https://www.webmd.com/fibromyalgia/guide/lyrica-for-fibromyalgia-treatment Lyrica for Fibromyalgia]<ref>{{Cite news | url=https://www.webmd.com/fibromyalgia/guide/lyrica-for-fibromyalgia-treatment| title = Lyrica for Fibromyalgia Treatment|work=WebMD|access-date=2018-08-12|language=en-US}}</ref>
*[https://www.sharecare.com/health/fibromyalgia-treatment-medications/lyrica-treat-nerve-pain-shingles How does Lyrica treat nerve pain from shingles?]<ref>{{Cite web|url=https://www.sharecare.com/health/fibromyalgia-treatment-medications/lyrica-treat-nerve-pain-shingles| title = How does Lyrica treat nerve pain from shingles? {{!}} Medications to Treat Fibromyalgia | last = Wiegman | first = Stacy | date = |website=Sharecare|language=en|archive-url=|archive-date=|url-status=|access-date=2018-08-12}}</ref>
*[http://press.pfizer.com/press-release/fda-approves-lyrica-management-neuropathic-pain-associated-spinal-cord-injury-based-pr FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review]<ref>{{Cite web|url=https://press.pfizer.com/press-release/fda-approves-lyrica-management-neuropathic-pain-associated-spinal-cord-injury-based-pr| title = FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review {{!}} Pfizer Pharmaceutical News and Media {{!}} Pfizer: the world's largest research-based pharmaceutical company|website=press.pfizer.com|language=en|access-date=2018-08-12}}</ref>
*[https://www.businesswire.com/news/home/20070301006277/en/FDA-Approves-Pfizers-Lyrica-Epilepsy-Add-On-Treatment FDA Approves Pregabalin as Epilepsy Add-On Treatment for Partial Onset Seizures]<ref>{{Cite news | url=https://www.businesswire.com/news/home/20070301006277/en/FDA-Approves-Pfizers-Lyrica-Epilepsy-Add-On-Treatment| title = FDA Approves Pfizer's Lyrica as Epilepsy Add-On Treatment for Partial Onset Seizures | last = | first =  | date = Jan 13, 2005|work=Business Wire|access-date=2018-08-12|archive-url=|archive-date=|url-status=|language=en}}</ref>

== References ==

[[Category:Potential treatments]]
[[Category:Analgesics]]
{{Reflist}}

[[Category:Anticonvulsants]]